Navigation Links
Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference

LOS ANGELES--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechnology, Inc. (OTCBB:CGRB) today announced that positive Phase I and Phase II data on the Company's prostate cancer drug candidate CB7630 (abiraterone acetate) were presented at the European Society for Medical Oncology (ESMO) Conference, which is currently taking place in Lugano, Switzerland. The data were presented in two oral and poster presentations on Sunday, July 8, as part of the session for genitourinary (prostate) cancer that took place. The poster presentations are further detailed below:

Inhibition of androgen synthesis results in high response rate in castration resistant prostate cancer

The Phase I/II trial of CB7630 was conducted at The Institute of Cancer Research and at The Royal Marsden NHS Foundation Trust in the United Kingdom. In the trial, CB7630 was administered orally, once daily, to chemotherapy-naive patients with castration resistant prostate cancer (CRPC), who had progressive disease despite treatment with LHRH analogues and multiple other hormonal therapies. To date, a total of 47 patients have been treated in the Phase I/II trial, including 15 patients treated in the Phase I portion of the trial and 32 patients treated in the Phase II portion of the trial. Of the 38 patients who were evaluable, all of the patients had radiological evidence of metastatic disease. Moreover, all of the patients had previously failed treatment with LHRH analogs and antiandrogens, while 20 patients (53%) had failed treatment with diethylstilboestrol and 19 patients (50%) had failed treatment with steroids.

In her poster and oral presentation, Dr. Alison Reid from The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust in the United Kingdom reported that CB7630 was well tolerated at doses as high as 2000 mg/day with minimal toxicity. Moreover, no dose limiting toxicity has been observed in the trial to date.

'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
3. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
7. Prana Biotechnology Presents New Key Findings on PBT2
8. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:9/23/2014)... , Sept. 23, 2014 Report ... study showing you trends, R&D and predicted revenues ... kinase inhibitors? Now get the latest analysis for ... trends, results, opportunities and revenue forecasts. Visiongain,s ... using protein kinase inhibition and related technology. There ...
(Date:9/23/2014)... BURLINGTON, Mass. , Sept. 23, 2014 ... in pricing and reimbursement (P&R) decision criteria ... along with expert insights into each country, ... messaging across different markets.  Global market access ... very specific market access requirements and challenges—and ...
(Date:9/23/2014)... 2014 Research and Markets  has announced the ... report to their offering. Diabetes is a ... Over 382 million people are estimated to be currently suffering ... 592 million by 2035. With a very high prevalence, ... and India , an increasing proportion ...
Breaking Medicine Technology:Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 2Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 4Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 5Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Va., July 8, 2011 The Amerigroup Foundation recently ... the Rx Partnership to benefit the Rockbridge Area Free ... organization that works to provide uninsured Virginians with access ... broker to access and distribute free bulk prescription medications ...
... /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" ... of premium branded Traditional Chinese Medicine ("TCM") consumer ... attending and presenting at the upcoming 2011 Global ... at the Intercontinental Hotel (888 Howard Street) in ...
Cached Medicine Technology:Amerigroup Foundation Presents Grant to Rx Partnership 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 3
(Date:9/23/2014)... single day event in Japan will be held ... Tokyo. Clinical data scientists will meet and discuss various topics ... single day event in China will be held November ... scientists attending this event will discuss topics around CDISC ADaM ... collected in clinical studies and beyond. , India will ...
(Date:9/23/2014)... ZEPHYRHILLS, FL (PRWEB) September 23, 2014 ... opening of the newly renovated Women’s Health Center ... square feet of space, the specially designed center ... women in East Pasco County. The Women’s Health ... and pelvic floor health, labor and delivery through ...
(Date:9/23/2014)... of California, Davis, and Academia Sinica, the preeminent ... have entered into a collaborative agreement to develop ... couples cutting-edge research with opportunities to translate innovative ... , The agreement was signed Sept.12 in Taipei ... UC Davis and President Chi-Huey Wong of Academia ...
(Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
(Date:9/23/2014)... -- A test used to diagnose lung cancer may not ... are more common, a new analysis says. One ... of what,s known as functional imaging. For lung cancer, a ... to the study authors. Cancerous tumors generally look different ... lungs that don,t have cancer, according to background information in ...
Breaking Medicine News(10 mins):Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2
... his team has performed an Endoscopic surgery for Frontal Sinus ... 25 years old patient in Venkateswara Hospital in Chennai, Tamilnadu, ... inflammation of the meninges that covers the brain and spinal ... fluid is produced in the inner ventricles of the brain ...
... the approval of the Government is attracting brickbats and bouquets. ... the scheme which the ICICI-Lombard is // meant ... some experts who contend that it will do no good ... system in the state. ,Every year all ...
... A unique world class healthcare facility, supported by Welcare World ... region. // A full service ambulatory health care service comprising ... services had been recently inagurated in Knowledge Village. ... open from 8 am to 11 pm and fucntions 6 ...
... has announced that five new Vietnamese provinces are infected by ... spread of bird flu virus as already more than 21 ... flu virus. Though, Vietnamese scientists have revealed that they have ... help to understand the mechanism of virus transmission and the ...
... high fat diet has been found to suppress the ... that regulates insulin secretion (beta cells of the pancreas). ... ,This molecular mechanism between diabetes (Type ... the University of California. During early stages of the ...
... the Yale School of Medicine has revealed that diet ... Until recently it was believed that there was a ... carbonated soft drinks. In their study published in the ... the researchers report that the link is unfounded, and ...
Cached Medicine News:Health News:Health Insurance Scheme Generates Conflicting Opinions 2Health News:State Of The Art Healthcare Facility Opened In 'New Dubai' by Welcare 2Health News:Soft Drinks May Reduce Esophageal Cancer Risk 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: